...
首页> 外文期刊>Environmental toxicology and pharmacology >Acute and twenty-eight days repeated oral dose toxicity study of besifloxacin in Wistar albino rats
【24h】

Acute and twenty-eight days repeated oral dose toxicity study of besifloxacin in Wistar albino rats

机译:贝司沙星对Wistar白化病大鼠的急性和第二十八天重复口服剂量毒性研究

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to investigate the potential acute and 28-day repeated oral toxicities of besifloxacin (BAF) in Wistar albino rats. In oral acute and repeated dose study, BAF was administered to both sex of rats, at dose levels of 0, 300, 600, 900 mg/kg/day and 0, 100, 200, 500 mg/kg/day, respectively. In the acute study, total white blood cell (WBC) (male, 43.74%; female, 42.60%) and total bilirubin (T-BIL) (male, 80%; female, 60%) were significantly increase, total protein (TP) (male, 23.24%; 27.80%) was significantly decreased, and significant incidence of pericholangitis (male, 83.33%; female, 75%) was shown in males and females of high-dose groups. In repeated oral dose toxicity study, similar type effects were also observed after serum hematological and serum biochemical analysis, whereas additionally sever hepatic injury and focal ulceration in gastric mucosa also observed in high dose groups of both sexes after histopathological analysis. However these toxic effects of besifloxacin were transient and reversible and no-observed adverse effect level (NOAEL) were 300 mg/kg/day for acute and 100 mg/kg/day for repeated dose toxicity study, respectively.
机译:这项研究的目的是调查Wistar白化病大鼠中贝西沙星(BAF)的潜在急性和28天重复口服毒性。在口服急性和重复剂量研究中,BAF分别以两种剂量分别以0、300、600、900 mg / kg /天和0、100、200、500 mg / kg /天的剂量施用于大鼠。在急性研究中,总白细胞(WBC)(男性,43.74%;女性,42.60%)和总胆红素(T-BIL)(男性,80%;女性,60%)显着增加,总蛋白(TP) )(男性,23.24%; 27.80%)显着降低,高剂量组的男性和女性均表现出明显的胆管炎发生率(男性,83.33%;女性,75%)。在重复的口服剂量毒性研究中,血清血液学和血清生化分析后也观察到了相似的类型效应,而高剂量组的男女在进行了病理组织学分析后也观察到严重的肝损伤和胃黏膜局灶性溃疡。然而,贝西沙星的这些毒性作用是短暂的和可逆的,对于重复剂量毒性研究,未观察到的不良反应水平(NOAEL)分别为300 mg / kg /天和100 mg / kg /天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号